Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis
Kristian Thorlund,1 Eric Druyts,2 J Antonio Aviña-Zubieta,3,4 Edward J Mills1,21Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; 2Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada; 3Department of Medicine, U...
Guardado en:
Autores principales: | Thorlund K, Druyts E, Aviña-Zubieta JA, Mills EJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e704285cf24d4cc3b1730965b21ad8da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis [Corrigendum]
por: Thorlund K, et al.
Publicado: (2014) -
Prevalence of Psoriatic Arthritis among Psoriatic Patients in Damietta Governorate
por: Aisha Mohamed, et al.
Publicado: (2019) -
The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis—Real-World Data from Dermatology Practice
por: Georgios Kokolakis, et al.
Publicado: (2021) -
Assessment of in vivo bone microarchitecture changes in an anti-TNFα treated psoriatic arthritic patient.
por: Enrico Soldati, et al.
Publicado: (2021) -
Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis
por: Sara Rahmati, et al.
Publicado: (2020)